Melanotan-2
MT-II, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Synthetic analogue of α-MSH that stimulates melanogenesis for skin tanning and may increase sexual arousal.
Completed
PHASE2
NCT02562716
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT00731731
Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00820872
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
Alliance for Clinical Trials in Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00066794
S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT03089944
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
AbbVie
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00693992
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00004067
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
NSABP Foundation Inc
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT06937931
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Ipsen
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE1
NCT03228537
Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT05586971
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
LG Chem
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00011999
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Radiation Therapy Oncology Group
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT03804944
Converting HR+ Breast Cancer Into an Individualized Vaccine
Weill Medical College of Cornell University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03175367
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
Regeneron Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT03829332
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)
Merck Sharp & Dohme LLC
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00352365
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT03914612
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT05112601
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03196219
A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult Subjects
Armata Pharmaceuticals, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE3
NCT00942357
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Gynecologic Oncology Group
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT00997152
Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
Akros Pharma Inc.
INTERVENTIONAL
Updated Dec 15, 2025